A New Pathway for Immune Cell Infiltration in Vascular Disease
A study in The American Journal of Pathology reveals a novel mechanism for how immune cells cross the vascular endothelium. Researchers found that Prostaglandin E2 (PGE2) signaling can trigger transendothelial migration independently of the classic CD31 (PECAM-1) adhesion molecule, both in laboratory models and in living organisms. This discovery challenges the established understanding of leukocyte extravasation, a fundamental process in inflammation, and identifies PGE2 as a potent regulator of vascular permeability and immune cell trafficking.
Why it might matter to you: This research directly intersects with the pathophysiology of atherosclerosis, where inflammatory cell infiltration into the vessel wall is a key driver of plaque formation and instability. For a cardiology-focused professional, understanding this CD31-independent pathway could inform new therapeutic strategies aimed at modulating vascular inflammation without disrupting essential hemostatic functions. It suggests that targeting specific prostaglandin signaling axes might offer a more nuanced approach to controlling the inflammatory component of cardiovascular diseases like coronary artery disease.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
